Dedes Ioannis, Kolovos Georgios, Fruscalzo Arrigo, Toub David, Vaineau Cloé, Lanz Susanne, Imboden Sara, Feki Anis, Mueller Michael D
Department of Obstetrics and Gynecology, University Hospital of Bern, University of Bern, 3010 Bern, Switzerland.
Department of Gynecology and Obstetrics, University Hospital of Fribourg, 1752 Fribourg, Switzerland.
J Clin Med. 2023 Apr 23;12(9):3069. doi: 10.3390/jcm12093069.
Adenomyosis is a common benign gynecologic condition characterized by ectopic endometrial glands and stroma in the myometrium causing pain (dysmenorrhea) and abnormal uterine bleeding. New interventional techniques have been introduced over recent years. This study evaluates the treatment success and side effects of radiofrequency ablation. An electronic literature search in the PubMed, Scopus, and ScienceDirect databases was carried out on the outcomes of pain reduction and, secondarily, on abnormal uterine bleeding, reintervention, reproductive outcome, imaging outcome, and complications. There was a mean decrease in dysmenorrhea pain scores by -63.4 ± 9.0% at 12 months. Data on other outcome parameters were sparse. No major complications were reported. Radiofrequency ablation represents a promising minimally invasive and organ-preserving treatment in patients with symptomatic adenomyosis. It is associated with clinically meaningful improvement of adenomyosis-related pain in the short term.
子宫腺肌病是一种常见的良性妇科疾病,其特征是子宫肌层中存在异位的子宫内膜腺体和间质,可导致疼痛(痛经)和异常子宫出血。近年来已引入了新的介入技术。本研究评估了射频消融的治疗成功率和副作用。在PubMed、Scopus和ScienceDirect数据库中进行了电子文献检索,检索内容包括疼痛减轻的结果,其次是异常子宫出血、再次干预、生殖结局、影像学结局和并发症。在12个月时,痛经疼痛评分平均下降了-63.4±9.0%。关于其他结局参数的数据较少。未报告重大并发症。射频消融对于有症状的子宫腺肌病患者而言是一种有前景的微创和保留器官的治疗方法。它与短期内子宫腺肌病相关疼痛的临床意义改善有关。